Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News The Binding Site product performs well in study

The Binding Site product performs well in study

22nd January 2010

The Binding Site’s serum-free light chain assay Freelite has been found to reduce labour-intensive immunofixation electrophoresis (IFE).

In a recent study, the firm’s serum-free light chain assay was discovered to reduce the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.

Carried out in Australia, the research was authored by Richard Fulton and Suran Fernando, who examined the optimal combination of laboratory tests to screen for monoclonal gammopathy.

“The FLC (free light chain) ratio is a more sensitive method than uIFE (urine immunofixation electrophoresis) in the detection of monoclonal light chains and may substantially reduce the need for onerous 24-hour urine collections,” the paper stated.

In other company news, the Binding Site unveiled a new website that was jointly developed in collaboration with professor Jo Bradwell.

It includes information on studies involving both Freelite serum-free light chain analysis and the new Hevylite heavy chain/light chain immunoglobulin analysis, informed the firm.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.